Skip to main content
Top
Published in: Virology Journal 1/2020

01-12-2020 | Cervical Cancer | Research

Temporal changes in the vaginal microbiota in self-samples and its association with persistent HPV16 infection and CIN2+

Authors: Malin Berggrund, Inger Gustavsson, Riina Aarnio, Julia Hedlund Lindberg, Karin Sanner, Ingrid Wikström, Stefan Enroth, Ignas Bunikis, Matts Olovsson, Ulf Gyllensten

Published in: Virology Journal | Issue 1/2020

Login to get access

Abstract

Background

The vaginal microbiota has been reported to be associated with HPV infection and cervical cancer. This study was performed to compare the vaginal microbiota at two timepoints in women performing self-sampling and had a persistent or transient HPV16 infection. The women were tested for 12 high-risk HPV (hrHPV) types but only women with single type (HPV16) were included to reduce confounding variables.

Methods

In total 96 women were included in this study. Of these, 26 were single positive for HPV16 in the baseline test and HPV negative in the follow-up test and 38 were single positive for HPV16 in both tests and diagnosed with CIN2+ in histology. In addition, 32 women that were negative for all 12 HPV tested were included. The samples of vaginal fluid were analyzed with the Ion 16S™ Metagenomics Kit and Ion 16S™ metagenomics module within the Ion Reporter™ software.

Results

K-means clustering resulted in two Lactobacillus-dominated groups, one with Lactobacillus sp. and the other specifically with Lactobacillus iners. The two remaining clusters were dominated by a mixed non-Lactobacillus microbiota. HPV negative women had lower prevalence (28%) of the non-Lactobacill dominant cluster in the baseline test, as compared to women with HPV16 infection (42%) (p value = 0.0173). Transition between clusters were more frequent in women with persistent HPV16 infection (34%) as compared in women who cleared the HPV16 infection (19%) (p value = 0.036).

Conclusions

The vaginal microbiota showed a higher rate of transitioning between bacterial profiles in women with persistent HPV16 infection as compared to women with transient infection. This indicate an instability in the microenvironment in women with persistent HPV infection and development of CIN2+.
Appendix
Available only for authorised users
Literature
1.
go back to reference Walboomers JM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12–9.PubMedCrossRef Walboomers JM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12–9.PubMedCrossRef
2.
go back to reference S. de Sanjose, M. Brotons, and M.A. Pavon, The natural history of human papillomavirus infection. Best Pract Res Clin Obstet Gynaecol, 2017. 47:2-13 S. de Sanjose, M. Brotons, and M.A. Pavon, The natural history of human papillomavirus infection. Best Pract Res Clin Obstet Gynaecol, 2017. 47:2-13
4.
go back to reference Castellsague X, Bosch FX, Munoz N. Environmental co-factors in HPV carcinogenesis. Virus Res. 2002;89(2):191–9.PubMedCrossRef Castellsague X, Bosch FX, Munoz N. Environmental co-factors in HPV carcinogenesis. Virus Res. 2002;89(2):191–9.PubMedCrossRef
5.
go back to reference Ravel J, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A. 2011;108(Suppl 1):4680–7.PubMedCrossRef Ravel J, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A. 2011;108(Suppl 1):4680–7.PubMedCrossRef
7.
go back to reference Godoy-Vitorino F, et al. Cervicovaginal fungi and bacteria associated with cervical intraepithelial neoplasia and high-risk human papillomavirus infections in a hispanic population. Front Microbiol. 2018;9:2533.PubMedPubMedCentralCrossRef Godoy-Vitorino F, et al. Cervicovaginal fungi and bacteria associated with cervical intraepithelial neoplasia and high-risk human papillomavirus infections in a hispanic population. Front Microbiol. 2018;9:2533.PubMedPubMedCentralCrossRef
8.
go back to reference Curty G, et al. Analysis of the cervical microbiome and potential biomarkers from postpartum HIV-positive women displaying cervical intraepithelial lesions. Sci Rep. 2017;7(1):17364.PubMedPubMedCentralCrossRef Curty G, et al. Analysis of the cervical microbiome and potential biomarkers from postpartum HIV-positive women displaying cervical intraepithelial lesions. Sci Rep. 2017;7(1):17364.PubMedPubMedCentralCrossRef
9.
go back to reference Di Paola M, et al. Characterization of cervico-vaginal microbiota in women developing persistent high-risk human papillomavirus infection. Sci Rep. 2017;7(1):10200.PubMedPubMedCentralCrossRef Di Paola M, et al. Characterization of cervico-vaginal microbiota in women developing persistent high-risk human papillomavirus infection. Sci Rep. 2017;7(1):10200.PubMedPubMedCentralCrossRef
10.
go back to reference Audirac-Chalifour A, et al. Cervical microbiome and cytokine profile at various stages of cervical cancer: a pilot study. PLoS ONE. 2016;11(4):e0153274.PubMedPubMedCentralCrossRef Audirac-Chalifour A, et al. Cervical microbiome and cytokine profile at various stages of cervical cancer: a pilot study. PLoS ONE. 2016;11(4):e0153274.PubMedPubMedCentralCrossRef
11.
go back to reference Shannon B, et al. Association of HPV infection and clearance with cervicovaginal immunology and the vaginal microbiota. Mucosal Immunol. 2017;10(5):1310–9.PubMedPubMedCentralCrossRef Shannon B, et al. Association of HPV infection and clearance with cervicovaginal immunology and the vaginal microbiota. Mucosal Immunol. 2017;10(5):1310–9.PubMedPubMedCentralCrossRef
12.
go back to reference Mitra A, et al. The vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: what do we know and where are we going next? Microbiome. 2016;4(1):58.PubMedPubMedCentralCrossRef Mitra A, et al. The vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: what do we know and where are we going next? Microbiome. 2016;4(1):58.PubMedPubMedCentralCrossRef
13.
14.
go back to reference Brotman RM, et al. Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection. J Infect Dis. 2014;210(11):1723–33.PubMedPubMedCentralCrossRef Brotman RM, et al. Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection. J Infect Dis. 2014;210(11):1723–33.PubMedPubMedCentralCrossRef
15.
go back to reference Reimers LL, et al. The cervicovaginal microbiota and its associations with human papillomavirus detection in HIV-infected and HIV-uninfected women. J Infect Dis. 2016;214(9):1361–9.PubMedPubMedCentralCrossRef Reimers LL, et al. The cervicovaginal microbiota and its associations with human papillomavirus detection in HIV-infected and HIV-uninfected women. J Infect Dis. 2016;214(9):1361–9.PubMedPubMedCentralCrossRef
17.
go back to reference Romero R, et al. The composition and stability of the vaginal microbiota of normal pregnant women is different from that of non-pregnant women. Microbiome. 2014;2(1):4.PubMedPubMedCentralCrossRef Romero R, et al. The composition and stability of the vaginal microbiota of normal pregnant women is different from that of non-pregnant women. Microbiome. 2014;2(1):4.PubMedPubMedCentralCrossRef
18.
go back to reference Rifkin SB, et al. Hormonal contraception and risk of bacterial vaginosis diagnosis in an observational study of women attending STD clinics in Baltimore. MD Contracep. 2009;80(1):63–7.CrossRef Rifkin SB, et al. Hormonal contraception and risk of bacterial vaginosis diagnosis in an observational study of women attending STD clinics in Baltimore. MD Contracep. 2009;80(1):63–7.CrossRef
19.
go back to reference Cherpes TL, et al. A delicate balance: risk factors for acquisition of bacterial vaginosis include sexual activity, absence of hydrogen peroxide-producing lactobacilli, black race, and positive herpes simplex virus type 2 serology. Sex Transm Dis. 2008;35(1):78–83.PubMedCrossRef Cherpes TL, et al. A delicate balance: risk factors for acquisition of bacterial vaginosis include sexual activity, absence of hydrogen peroxide-producing lactobacilli, black race, and positive herpes simplex virus type 2 serology. Sex Transm Dis. 2008;35(1):78–83.PubMedCrossRef
20.
go back to reference Watts GS, et al. 16S rRNA gene sequencing on a benchtop sequencer: accuracy for identification of clinically important bacteria. J Appl Microbiol. 2017;123(6):1584–96.PubMedPubMedCentralCrossRef Watts GS, et al. 16S rRNA gene sequencing on a benchtop sequencer: accuracy for identification of clinically important bacteria. J Appl Microbiol. 2017;123(6):1584–96.PubMedPubMedCentralCrossRef
21.
go back to reference Salipante SJ, et al. Performance comparison of Illumina and ion torrent next-generation sequencing platforms for 16S rRNA-based bacterial community profiling. Appl Environ Microbiol. 2014;80(24):7583–91.PubMedPubMedCentralCrossRef Salipante SJ, et al. Performance comparison of Illumina and ion torrent next-generation sequencing platforms for 16S rRNA-based bacterial community profiling. Appl Environ Microbiol. 2014;80(24):7583–91.PubMedPubMedCentralCrossRef
22.
go back to reference Gustavsson I, et al. Randomised study shows that repeated self-sampling and HPV test has more than two-fold higher detection rate of women with CIN2+ histology than Pap smear cytology. Br J Cancer. 2018;118(6):896–904.PubMedPubMedCentralCrossRef Gustavsson I, et al. Randomised study shows that repeated self-sampling and HPV test has more than two-fold higher detection rate of women with CIN2+ histology than Pap smear cytology. Br J Cancer. 2018;118(6):896–904.PubMedPubMedCentralCrossRef
23.
go back to reference Gustavsson I, et al. Type-specific detection of high-risk human papillomavirus (HPV) in self-sampled cervicovaginal cells applied to FTA elute cartridge. J Clin Virol. 2011;51(4):255–8.PubMedCrossRef Gustavsson I, et al. Type-specific detection of high-risk human papillomavirus (HPV) in self-sampled cervicovaginal cells applied to FTA elute cartridge. J Clin Virol. 2011;51(4):255–8.PubMedCrossRef
24.
go back to reference Gustavsson I, et al. Use of FTA card for dry collection, transportation and storage of cervical cell specimen to detect high-risk HPV. J Clin Virol. 2009;46(2):112–6.PubMedCrossRef Gustavsson I, et al. Use of FTA card for dry collection, transportation and storage of cervical cell specimen to detect high-risk HPV. J Clin Virol. 2009;46(2):112–6.PubMedCrossRef
25.
go back to reference Gustavsson I, et al. Comparison between the hybrid capture 2 and the hpVIR real-time PCR for detection of human papillomavirus in women with ASCUS or low grade dysplasia. J Clin Virol. 2009;45(2):85–9.PubMedCrossRef Gustavsson I, et al. Comparison between the hybrid capture 2 and the hpVIR real-time PCR for detection of human papillomavirus in women with ASCUS or low grade dysplasia. J Clin Virol. 2009;45(2):85–9.PubMedCrossRef
26.
go back to reference Gustavsson I, et al. Clinical validation of the HPVIR high-risk HPV test on cervical samples according to the international guidelines for human papillomavirus DNA test requirements for cervical cancer screening. Virol J. 2019;16(1):107.PubMedPubMedCentralCrossRef Gustavsson I, et al. Clinical validation of the HPVIR high-risk HPV test on cervical samples according to the international guidelines for human papillomavirus DNA test requirements for cervical cancer screening. Virol J. 2019;16(1):107.PubMedPubMedCentralCrossRef
27.
go back to reference R Core Team. R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing; 2014. R Core Team. R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing; 2014.
28.
go back to reference Kolde R. Pheatmap: pretty heatmaps. R Package Version. 2012;61:1–7. Kolde R. Pheatmap: pretty heatmaps. R Package Version. 2012;61:1–7.
29.
go back to reference Jari Oksanen RK, Legendre P, O’Hara B, Henry M, Stevens H. Maintainer Jari Oksanen, MASS Suggests. The vegan package Community Ecology Package. 2007;10:631–7. Jari Oksanen RK, Legendre P, O’Hara B, Henry M, Stevens H. Maintainer Jari Oksanen, MASS Suggests. The vegan package Community Ecology Package. 2007;10:631–7.
30.
31.
go back to reference Norenhag J, et al. The vaginal microbiota, human papillomavirus and cervical dysplasia: a systematic review and network meta-analysis. BJOG. 2019;127(2):171–80.PubMedCrossRef Norenhag J, et al. The vaginal microbiota, human papillomavirus and cervical dysplasia: a systematic review and network meta-analysis. BJOG. 2019;127(2):171–80.PubMedCrossRef
32.
go back to reference Onywera H, et al. The cervical microbiota in reproductive-age South African women with and without human papillomavirus infection. Papillomavirus Res. 2019;7:154–63.PubMedPubMedCentralCrossRef Onywera H, et al. The cervical microbiota in reproductive-age South African women with and without human papillomavirus infection. Papillomavirus Res. 2019;7:154–63.PubMedPubMedCentralCrossRef
33.
go back to reference Di Pietro M, et al. HPV/Chlamydia trachomatis co-infection: metagenomic analysis of cervical microbiota in asymptomatic women. New Microbiol. 2018;41(1):34–41.PubMed Di Pietro M, et al. HPV/Chlamydia trachomatis co-infection: metagenomic analysis of cervical microbiota in asymptomatic women. New Microbiol. 2018;41(1):34–41.PubMed
34.
go back to reference Arokiyaraj S, et al. Association of cervical microbial community with persistence, clearance and negativity of human papillomavirus in Korean women: a longitudinal study. Sci Rep. 2018;8(1):15479.PubMedPubMedCentralCrossRef Arokiyaraj S, et al. Association of cervical microbial community with persistence, clearance and negativity of human papillomavirus in Korean women: a longitudinal study. Sci Rep. 2018;8(1):15479.PubMedPubMedCentralCrossRef
35.
go back to reference Moody CA, Laimins LA. Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer. 2010;10(8):550–60.PubMedCrossRef Moody CA, Laimins LA. Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer. 2010;10(8):550–60.PubMedCrossRef
36.
go back to reference Karim R, et al. Human papillomavirus deregulates the response of a cellular network comprising of chemotactic and proinflammatory genes. PLoS ONE. 2011;6(3):e17848.PubMedPubMedCentralCrossRef Karim R, et al. Human papillomavirus deregulates the response of a cellular network comprising of chemotactic and proinflammatory genes. PLoS ONE. 2011;6(3):e17848.PubMedPubMedCentralCrossRef
37.
go back to reference Niebler M, et al. Post-translational control of IL-1beta via the human papillomavirus type 16 E6 oncoprotein: a novel mechanism of innate immune escape mediated by the E3-ubiquitin ligase E6-AP and p53. PLoS Pathog. 2013;9(8):e1003536.PubMedPubMedCentralCrossRef Niebler M, et al. Post-translational control of IL-1beta via the human papillomavirus type 16 E6 oncoprotein: a novel mechanism of innate immune escape mediated by the E3-ubiquitin ligase E6-AP and p53. PLoS Pathog. 2013;9(8):e1003536.PubMedPubMedCentralCrossRef
38.
go back to reference Hammes LS, et al. Macrophages, inflammation and risk of cervical intraepithelial neoplasia (CIN) progression–clinicopathological correlation. Gynecol Oncol. 2007;105(1):157–65.PubMedCrossRef Hammes LS, et al. Macrophages, inflammation and risk of cervical intraepithelial neoplasia (CIN) progression–clinicopathological correlation. Gynecol Oncol. 2007;105(1):157–65.PubMedCrossRef
39.
40.
go back to reference Arbyn M, et al. Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses. BMJ. 2018;363:k4823.PubMedPubMedCentralCrossRef Arbyn M, et al. Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses. BMJ. 2018;363:k4823.PubMedPubMedCentralCrossRef
41.
go back to reference Herweijer E, et al. The participation of HPV-vaccinated women in a National Cervical Screening Program: Population-Based Cohort Study. PLoS ONE. 2015;10(7):e0134185.PubMedPubMedCentralCrossRef Herweijer E, et al. The participation of HPV-vaccinated women in a National Cervical Screening Program: Population-Based Cohort Study. PLoS ONE. 2015;10(7):e0134185.PubMedPubMedCentralCrossRef
43.
go back to reference Achilles SL, et al. Impact of contraceptive initiation on vaginal microbiota. Am J Obstet Gynecol. 2018;218(6):622e1–622e10.CrossRef Achilles SL, et al. Impact of contraceptive initiation on vaginal microbiota. Am J Obstet Gynecol. 2018;218(6):622e1–622e10.CrossRef
44.
go back to reference Wessels JM, et al. Association of high-risk sexual behaviour with diversity of the vaginal microbiota and abundance of Lactobacillus. PLoS ONE. 2017;12(11):e0187612.PubMedPubMedCentralCrossRef Wessels JM, et al. Association of high-risk sexual behaviour with diversity of the vaginal microbiota and abundance of Lactobacillus. PLoS ONE. 2017;12(11):e0187612.PubMedPubMedCentralCrossRef
Metadata
Title
Temporal changes in the vaginal microbiota in self-samples and its association with persistent HPV16 infection and CIN2+
Authors
Malin Berggrund
Inger Gustavsson
Riina Aarnio
Julia Hedlund Lindberg
Karin Sanner
Ingrid Wikström
Stefan Enroth
Ignas Bunikis
Matts Olovsson
Ulf Gyllensten
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2020
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-020-01420-z

Other articles of this Issue 1/2020

Virology Journal 1/2020 Go to the issue